Design On Performance Evaluation Of JHZY Group Based On Balanced Scorecard

With the deepening of drug system reform and the intensification of industry competition,the speed of reshuffling of pharmaceutical production enterprises is obvious,the arrival of knowledge economy forces JHZY group to higher requirements of human resources management,higher requirements for managers.Managers must find effective measures to improve the efficiency of the organization and to mobilize the enthusiasm of the staff.At present,many pharmaceutical enterprises have not constructed the performance evaluation management mechanism which accords with the management requirements of modern pharmaceutical enterprises.The performance evaluation system of JHZY group has been difficult to meet the rapid development needs of the group,and the reform of performance management system is imperative.In this paper,the performance evaluation system of JHZY group is the research object,based on the performance management and balanced scorecard theory,the performance of jhzy group is studied by questionnaire,analytic hierarchy process and other related research methods.This paper first introduces the development of the balanced scorecard theory abroad,then introduces the current situation of the balanced scorecard in China,and then through the questionnaire to identify the problems in performance evaluation of JHZY group;This paper introduces the necessity of introducing the balanced scorecard into the performance evaluation system of JHZY group,combined with the development status of JHZY group,clearly adopts the idea and principle of balanced scorecard performance evaluation,select the performance evaluation of the dimension and corresponding index weight,and set and apply the relevant weight.Finally,the summary and prospect,points out the problems and deficiencies in the research.Based on the status of performance appraisal of JHZY group,combining theory and practice,the balanced scorecard reference to the performance appraisal of JHZY group,expects the research results can be reference value for the performance evaluation of similar pharmaceutical enterprises.